Inova Health Care Services

• Abdulla Al Damluji

Sources: reporter.nih.gov

• NCT07831369

  Phase 2, Recruiting, 52 people, 21 Sept 2026

• NCT07023666

  Phase 2, Recruiting, 100 people, 17 Jun 2025

• The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

  Phase 2, Recruiting, 19 people, 23 Jan 2025

• NCT06501989

  Phase 2, Withdrawn, 0 people, 15 Jul 2024

• NCT06007846

  Phase 2/3, Recruiting, 12 people, 23 Aug 2023

• NCT04328883

  Phase 1, Completed, 19 people, 1 Apr 2020

• NCT03679013

  Phase 2, Completed, 19 people, 20 Sept 2018

• NCT03258281

  Phase 4, Terminated, 4 people, 23 Aug 2017

• NCT03207451

  Phase 4, Completed, 81 people, 2 Jul 2017

• NCT02936999

  Early phase 1, Terminated, 8 people, 18 Oct 2016

• NCT01963728

  Phase 4, Terminated, 2 people, 16 Oct 2013

• NCT01023477

  Phase 1/2, Completed, 12 people, 2 Dec 2009

Sources: clinicaltrials.gov

• National Heart, Lung, and Blood Institute

  K23, Frailty and Resiliency in Older Adults with Acute Myocardial Infarction, K23HL153771, US$183.1k, 2020–2025, 24 Jul 2023

Sources: reporter.nih.gov